Medicine for treating erythronoclastic anemia
A technology for hemolytic anemia and therapeutic drug is applied in the field of therapeutic drug for hemolytic anemia to achieve obvious and stable effect.
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2016-04-06
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a medicine for treating hemolytic anemia, in particular to a medicine for treating hemolytic anemia, belonging to the technical field of medicine. Background technique
[0002] Hemolytic anemia refers to a type of anemia that occurs when red blood cell destruction is accelerated and bone marrow hematopoietic function is insufficiently compensated. Anemia does not occur if the bone marrow is able to increase red blood cell production sufficiently to compensate for the shortened lifespan of red blood cells, a state called compensated hemolytic disease. "Hemolytic anemia", anemia caused by excessive destruction of red blood cells, but less common; often accompanied by jaundice, called "hemolytic jaundice".
[0003] The etiology of hemolytic anemia: According to the reasons for the shortened lifespan of red blood cells, it can be divided into hemolytic anemia caused by intrinsic defects of red blood cells and external factors. 1....
Examples
Embodiment Construction
[0010] A medicine for treating hemolytic anemia in an amount suitable for a patient with hemolytic anemia is further described as a preferred embodiment.
[0011] A dose of medicine for treating hemolytic anemia is composed of the following Chinese medicines: 15 grams of mulberries, 15 grams of leeches, 15 grams of Rehmannia glutinosa, 10 grams of seaweed, 15 grams of Tianjihuang, 15 grams of codonopsis, and 10 grams of red dates , Achyranthes bidentata 18 grams, turtle shell 15 grams, astragalus 15 grams, yam 20 grams, licorice 7 grams. A method of using a medicine for treating hemolytic anemia: taking decoction orally, taking one dose a day, taking 15 consecutive days as a course of treatment, after which the dose can be slightly reduced due to the relief of symptoms.